Wiktoria Toczek
Wiktoria Toczek has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Klaudia Bogdan
Ludwik Rydygier Specialist Hospital in Cracow, os. Zlotej Jesieni 1, 31-826 Kraków, Poland
9 shared publications - Mikołaj Jankowski
Ludwik Rydygier Specialist Hospital in Cracow, os. Złotej Jesieni 1, 31-826 Kraków, Poland
9 shared publications - Natalia Ciepluch
Municipal Hospital No. 4 in Gliwice, Zygmunta Starego 20, 44-100 Gliwice, Poland
9 shared publications - Szymon Słomiński
University Clinical Hospital in Poznań, Przybyszewskiego 49, 60-355 Poznań, Poland
9 shared publications - Urszula Janicka
Lower Silesian Center of Oncology, Pulmonology and Hematology, Plac Ludwika Hirszfelda 12, 53-413 Wrocław, Poland
9 shared publications - Magdalena Olszówka
Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Lublin, Poland
7 shared publications
Latest Publications
- Open Access
- 18 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67591
Pelvic Floor Dysfunction in Athletes: Risk Factors, Prevention, and Rehabilitation – A Narrative Review
Pelvic floor dysfunction (PFD) is increasingly recognized among athletic populations of both sexes, particularly in sports characterized by repetitive high-impact loading, sustained elevations in intra-abdominal pressure, and high training volumes. Clinical manifestations include urinary incontinence, pelvic pain, voiding disturbances, and, less frequently, prolapse-related symptoms, which may negatively affect performance and quality of life. Although physical activity confers substantial health benefits, sport-specific mechanical and neuromuscular demands may exceed pelvic floor adaptive capacity in susceptible individuals. This narrative review synthesizes contemporary evidence (2020–2025) regarding the epidemiology of PFD in athletes, underlying biomechanical and neuromuscular mechanisms, sport-specific risk factors, and evidence-based strategies for prevention and rehabilitation. Practical implications for screening, training-load management, and multidisciplinary care in athletic populations are discussed.
- 18 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67591
Open AccessPelvic Floor Dysfunction in Athletes: Risk Factors, Prevention, and Rehabilitation – A Narrative Review
Pelvic floor dysfunction (PFD) is increasingly recognized among athletic populations of both sexes, particularly in sports characterized by repetitive high-impact loading, sustained elevations in intra-abdominal pressure, and high training volumes. Clinical manifestations include urinary incontinence, pelvic pain, voiding disturbances, and, less frequently, prolapse-related symptoms, which may negatively affect performance and quality of life. Although physical activity confers substantial health benefits, sport-specific mechanical and neuromuscular demands may exceed pelvic floor adaptive capacity in susceptible individuals. This narrative review synthesizes contemporary evidence (2020–2025) regarding the epidemiology of PFD in athletes, underlying biomechanical and neuromuscular mechanisms, sport-specific risk factors, and evidence-based strategies for prevention and rehabilitation. Practical implications for screening, training-load management, and multidisciplinary care in athletic populations are discussed.
- Open Access
- 18 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67747
The Preventive Role of Regular Physical Activity in Non-Specific Low Back Pain Among Physically Active Adults – A Literature Review
Background.Non-specific low back pain (NSLBP) is one of the most prevalent musculoskeletal disorders and a leading cause of disability among adults worldwide. Although physically active individuals are generally considered healthier, they remain susceptible to NSLBP, particularly when training loads are improperly managed or recovery is insufficient. Contemporary clinical guidelines increasingly emphasize non-pharmacological approaches, especially physical activity, as a cornerstone of NSLBP prevention. Aim. The aim of this narrative literature review was to evaluate the preventive role of regular physical activity in non-specific low back pain, with particular emphasis on physically active and recreationally active adults. Materials and Methods.A narrative review of the literature was conducted using the PubMed and Scopus databases. Peer-reviewed articles published between 2015 and 2024 were analyzed, including systematic reviews, meta-analyses, randomized controlled trials, and international clinical guidelines. Studies focusing on specific spinal pathologies or postoperative populations were excluded. Results.The analyzed evidence consistently indicates that regular physical activity is associated with a reduced risk of NSLBP onset and recurrence. Aerobic exercise, resistance training, and core stabilization programs were shown to improve spinal stability, functional capacity, and quality of life, while reducing pain-related disability. Multimodal exercise programs demonstrated the most favorable preventive outcomes. Conclusions.Regular physical activity plays a crucial role in the prevention of non-specific low back pain among physically active adults. Appropriately prescribed aerobic exercise, resistance training, and core stabilization exercises should be incorporated into preventive strategies aimed at reducing the burden of NSLBP.
- 18 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67747
Open AccessThe Preventive Role of Regular Physical Activity in Non-Specific Low Back Pain Among Physically Active Adults – A Literature Review
Background.Non-specific low back pain (NSLBP) is one of the most prevalent musculoskeletal disorders and a leading cause of disability among adults worldwide. Although physically active individuals are generally considered healthier, they remain susceptible to NSLBP, particularly when training loads are improperly managed or recovery is insufficient. Contemporary clinical guidelines increasingly emphasize non-pharmacological approaches, especially physical activity, as a cornerstone of NSLBP prevention. Aim. The aim of this narrative literature review was to evaluate the preventive role of regular physical activity in non-specific low back pain, with particular emphasis on physically active and recreationally active adults. Materials and Methods.A narrative review of the literature was conducted using the PubMed and Scopus databases. Peer-reviewed articles published between 2015 and 2024 were analyzed, including systematic reviews, meta-analyses, randomized controlled trials, and international clinical guidelines. Studies focusing on specific spinal pathologies or postoperative populations were excluded. Results.The analyzed evidence consistently indicates that regular physical activity is associated with a reduced risk of NSLBP onset and recurrence. Aerobic exercise, resistance training, and core stabilization programs were shown to improve spinal stability, functional capacity, and quality of life, while reducing pain-related disability. Multimodal exercise programs demonstrated the most favorable preventive outcomes. Conclusions.Regular physical activity plays a crucial role in the prevention of non-specific low back pain among physically active adults. Appropriately prescribed aerobic exercise, resistance training, and core stabilization exercises should be incorporated into preventive strategies aimed at reducing the burden of NSLBP.
- Open Access
- 18 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67765
Omega-3 Fatty Acids and Renal Health: Mechanisms, Protective Effects and Clinical Implications – A Narrative Review
Background: Chronic kidney disease (CKD) is a major global health problem associated with increased cardiovascular risk, progressive renal function decline, and high mortality. Despite advances in pharmacological therapy, disease progression often persists, highlighting the need for supportive, lifestyle-based interventions. Omega-3 polyunsaturated fatty acids (PUFAs) have gained interest in nephrology due to their anti-inflammatory, anti-oxidative, and endothelial-protective properties. Aim of the study: This narrative review aimed to summarize current evidence on the role of omega-3 PUFAs, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in renal health, with emphasis on mechanistic pathways and clinical implications in chronic kidney disease and inflammation-related renal injury. Materials and methods: A narrative literature review was conducted using PubMed, Scopus, and Google Scholar. Publications from 2020–2025 were prioritized, including randomized controlled trials, systematic reviews, meta-analyses, and experimental studies. Search terms included omega-3 fatty acids, EPA, DHA, chronic kidney disease, proteinuria, renal inflammation, and fibrosis. Current stage of knowledge: Omega-3 fatty acids exert pleiotropic effects relevant to renal protection, including modulation of inflammatory signaling, oxidative stress, mitochondrial dysfunction, endothelial function, and fibrotic pathways. Clinical data suggest modest but consistent reductions in proteinuria, particularly in IgA nephropathy and early-stage CKD, while effects on long-term renal function decline remain inconsistent. Conclusions: Omega-3 fatty acids may offer supportive renoprotective benefits, especially in proteinuric and inflammation-mediated kidney diseases. They should be considered an adjunct to established therapies. Further long-term studies are needed to identify optimal dosing and patient populations most likely to benefit.
- 18 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67765
Open AccessOmega-3 Fatty Acids and Renal Health: Mechanisms, Protective Effects and Clinical Implications – A Narrative Review
Background: Chronic kidney disease (CKD) is a major global health problem associated with increased cardiovascular risk, progressive renal function decline, and high mortality. Despite advances in pharmacological therapy, disease progression often persists, highlighting the need for supportive, lifestyle-based interventions. Omega-3 polyunsaturated fatty acids (PUFAs) have gained interest in nephrology due to their anti-inflammatory, anti-oxidative, and endothelial-protective properties. Aim of the study: This narrative review aimed to summarize current evidence on the role of omega-3 PUFAs, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in renal health, with emphasis on mechanistic pathways and clinical implications in chronic kidney disease and inflammation-related renal injury. Materials and methods: A narrative literature review was conducted using PubMed, Scopus, and Google Scholar. Publications from 2020–2025 were prioritized, including randomized controlled trials, systematic reviews, meta-analyses, and experimental studies. Search terms included omega-3 fatty acids, EPA, DHA, chronic kidney disease, proteinuria, renal inflammation, and fibrosis. Current stage of knowledge: Omega-3 fatty acids exert pleiotropic effects relevant to renal protection, including modulation of inflammatory signaling, oxidative stress, mitochondrial dysfunction, endothelial function, and fibrotic pathways. Clinical data suggest modest but consistent reductions in proteinuria, particularly in IgA nephropathy and early-stage CKD, while effects on long-term renal function decline remain inconsistent. Conclusions: Omega-3 fatty acids may offer supportive renoprotective benefits, especially in proteinuric and inflammation-mediated kidney diseases. They should be considered an adjunct to established therapies. Further long-term studies are needed to identify optimal dosing and patient populations most likely to benefit.
- Open Access
- 7 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67583
Targeting Schizophrenia: A Review of Pharmacological and Psychosocial Innovations
Background. Paranoid schizophrenia is the most common subtype of schizophrenia, characterized by both positive symptoms, such as hallucinations and delusions, and negative symptoms like reduced motivation and social withdrawal. While pharmacological advances have improved symptom control, challenges remain in treating negative symptoms and ensuring long-term adherence and recovery. Aim of the study. This review analyzes recent literature (2020–2025) on pharmacological and psychosocial treatment strategies for paranoid schizophrenia, with attention to effectiveness, tolerability, and integration. Materials and methods. PubMed and Google Scholar were searched for meta-analyses, RCTs, and guidelines published in the last 5 years using terms like “paranoid schizophrenia”, “antipsychotics”, “long-acting injectables”, “CBT”, “treatment”. Current stage of knowledge. Modern antipsychotics, particularly SGAs and LAIs, reduce relapse risk and enhance adherence. Cariprazine and newer agents like Cobenfy show promise in treating negative and treatment-resistant cases. Integration with psychosocial strategies—especially CBT and family interventions—enhances functional recovery, though results for negative symptoms remain mixed. Novel treatments target glutamatergic and cholinergic systems beyond traditional dopaminergic focus. Conclusions. A multimodal approach is essential. Future treatment should emphasize personalized strategies, early intervention, targeting of non-dopaminergic pathways, and better access to integrated care, particularly for patients with persistent negative or cognitive symptoms.
- 7 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67583
Open AccessTargeting Schizophrenia: A Review of Pharmacological and Psychosocial Innovations
Background. Paranoid schizophrenia is the most common subtype of schizophrenia, characterized by both positive symptoms, such as hallucinations and delusions, and negative symptoms like reduced motivation and social withdrawal. While pharmacological advances have improved symptom control, challenges remain in treating negative symptoms and ensuring long-term adherence and recovery. Aim of the study. This review analyzes recent literature (2020–2025) on pharmacological and psychosocial treatment strategies for paranoid schizophrenia, with attention to effectiveness, tolerability, and integration. Materials and methods. PubMed and Google Scholar were searched for meta-analyses, RCTs, and guidelines published in the last 5 years using terms like “paranoid schizophrenia”, “antipsychotics”, “long-acting injectables”, “CBT”, “treatment”. Current stage of knowledge. Modern antipsychotics, particularly SGAs and LAIs, reduce relapse risk and enhance adherence. Cariprazine and newer agents like Cobenfy show promise in treating negative and treatment-resistant cases. Integration with psychosocial strategies—especially CBT and family interventions—enhances functional recovery, though results for negative symptoms remain mixed. Novel treatments target glutamatergic and cholinergic systems beyond traditional dopaminergic focus. Conclusions. A multimodal approach is essential. Future treatment should emphasize personalized strategies, early intervention, targeting of non-dopaminergic pathways, and better access to integrated care, particularly for patients with persistent negative or cognitive symptoms.
- Open Access
- 5 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67584
Physical Activity and Lower Urinary Tract Function: Pathophysiological Mechanisms, Clinical Evidence, and Practical Implications – A Narrative Review
Lower urinary tract function (LUTF) depends on complex interactions between the detrusor muscle, urethral sphincters, pelvic floor musculature, and central and peripheral neural control. Disruption of these mechanisms may lead to lower urinary tract symptoms (LUTS), including urinary incontinence, urgency, frequency, nocturia, and voiding dysfunction, which substantially impair quality of life and participation in physical activity. Physical activity is a modifiable lifestyle factor that may exert both beneficial and adverse effects on urinary tract function. Moderate, well-structured exercise enhances pelvic floor muscle strength, neuromuscular coordination, metabolic health, and autonomic regulation, whereas excessive or high-impact training may exceed pelvic floor adaptive capacity and increase susceptibility to LUTS. This narrative review synthesizes contemporary evidence (2020–2025) regarding epidemiology, pathophysiological mechanisms, sport-specific risk profiles, and clinical outcomes related to physical activity and LUTF, and discusses practical implications for screening, prevention, and clinical management in physically active populations.
- 5 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67584
Open AccessPhysical Activity and Lower Urinary Tract Function: Pathophysiological Mechanisms, Clinical Evidence, and Practical Implications – A Narrative Review
Lower urinary tract function (LUTF) depends on complex interactions between the detrusor muscle, urethral sphincters, pelvic floor musculature, and central and peripheral neural control. Disruption of these mechanisms may lead to lower urinary tract symptoms (LUTS), including urinary incontinence, urgency, frequency, nocturia, and voiding dysfunction, which substantially impair quality of life and participation in physical activity. Physical activity is a modifiable lifestyle factor that may exert both beneficial and adverse effects on urinary tract function. Moderate, well-structured exercise enhances pelvic floor muscle strength, neuromuscular coordination, metabolic health, and autonomic regulation, whereas excessive or high-impact training may exceed pelvic floor adaptive capacity and increase susceptibility to LUTS. This narrative review synthesizes contemporary evidence (2020–2025) regarding epidemiology, pathophysiological mechanisms, sport-specific risk profiles, and clinical outcomes related to physical activity and LUTF, and discusses practical implications for screening, prevention, and clinical management in physically active populations.
- Open Access
- 28 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Rheumatoid Arthritis and Mental Health: An In-Depth Review
Background/Objective: Rheumatoid arthritis (RA) co-occurs with depression and anxiety, driven by shared inflammatory pathways, that impair quality of life and treatment response. This review synthesizes evidence on biological mechanisms, biomarkers, and therapeutic strategies targeting RA-related depression. Methods: Narrative synthesis of epidemiological, biomarker, pharmacological and lifestyle studies linking RA inflammation to mental health. Results: Pro-inflammatory cytokines (IL-6, TNF-α) mediate the RA-depression nexus, while elevated IL-6, TNF-α, and CRP levels can be used for predicting depression risk. IL-6 inhibitors, TNF inhibitors and JAK inhibitors demonstrate significant improvement in mental state of the patients. SSRIs/SNRIs provide help in maintaining high-minded mood and pain relief, while Mediterranean diet adherence can halve depression odds. Emerging preclinical data support neuroimmune modulators like aucubin targeting CXCL10/BTN3A2. Conclusion: Integrated care combining cytokine-targeted therapies, antidepressants, psychological interventions, and anti-inflammatory lifestyle measures optimizes outcomes for RA patients with depression, emphasizing early screening and holistic management.
- 28 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Open AccessRheumatoid Arthritis and Mental Health: An In-Depth Review
Background/Objective: Rheumatoid arthritis (RA) co-occurs with depression and anxiety, driven by shared inflammatory pathways, that impair quality of life and treatment response. This review synthesizes evidence on biological mechanisms, biomarkers, and therapeutic strategies targeting RA-related depression. Methods: Narrative synthesis of epidemiological, biomarker, pharmacological and lifestyle studies linking RA inflammation to mental health. Results: Pro-inflammatory cytokines (IL-6, TNF-α) mediate the RA-depression nexus, while elevated IL-6, TNF-α, and CRP levels can be used for predicting depression risk. IL-6 inhibitors, TNF inhibitors and JAK inhibitors demonstrate significant improvement in mental state of the patients. SSRIs/SNRIs provide help in maintaining high-minded mood and pain relief, while Mediterranean diet adherence can halve depression odds. Emerging preclinical data support neuroimmune modulators like aucubin targeting CXCL10/BTN3A2. Conclusion: Integrated care combining cytokine-targeted therapies, antidepressants, psychological interventions, and anti-inflammatory lifestyle measures optimizes outcomes for RA patients with depression, emphasizing early screening and holistic management.
- Open Access
- 28 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
The Gut Microbiome in Athletes: Mechanisms, Training Adaptations, and Implications for Performance — A Comprehensive Review
BackgroundThe gut microbiota is increasingly seen as a key regulator of functions relevant to athletic performance. Exercise alters microbial composition, while microbial metabolites influence metabolism, immunity, gut barrier integrity, and recovery. Despite rapid growth of research, findings are inconsistent, underscoring the need for clearer mechanisms. This review summarizes current evidence on the bidirectional relationship between training and the gut microbiota and its implications for performance. AimTo consolidate open-access research on links between gut microbiota, exercise physiology, and performance, focusing on metabolic pathways, gut–muscle communication, immune modulation, intestinal permeability, and training-specific effects. Material and MethodsThis narrative review draws on open-access literature up to 2025, identified through PubMed, PMC, and Google Scholar. Included studies comprise mechanistic animal work, observational data, randomized trials, and systematic reviews examining physical activity, microbiota composition, microbial metabolites, and performance in athletes. ResultsEndurance training induces microbial adaptations, including increases in taxa metabolizing lactate and generating propionate. Strength and HIIT training show more variable changes shaped by diet, training load, and metabolic health. Microbial metabolites—especially SCFAs—may enhance energy regulation, immune balance, and gut barrier function, though evidence remains fragmented and causality unclear. ConclusionThe gut microbiota is a dynamic component of exercise adaptation. While diverse and SCFA-producing microbes appear beneficial for metabolism, inflammation control, and recovery, overall findings are heterogeneous. More interdisciplinary research is needed to clarify causal pathways and support personalized, microbiome-based strategies in sports nutrition and training.
- 28 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Open AccessThe Gut Microbiome in Athletes: Mechanisms, Training Adaptations, and Implications for Performance — A Comprehensive Review
BackgroundThe gut microbiota is increasingly seen as a key regulator of functions relevant to athletic performance. Exercise alters microbial composition, while microbial metabolites influence metabolism, immunity, gut barrier integrity, and recovery. Despite rapid growth of research, findings are inconsistent, underscoring the need for clearer mechanisms. This review summarizes current evidence on the bidirectional relationship between training and the gut microbiota and its implications for performance. AimTo consolidate open-access research on links between gut microbiota, exercise physiology, and performance, focusing on metabolic pathways, gut–muscle communication, immune modulation, intestinal permeability, and training-specific effects. Material and MethodsThis narrative review draws on open-access literature up to 2025, identified through PubMed, PMC, and Google Scholar. Included studies comprise mechanistic animal work, observational data, randomized trials, and systematic reviews examining physical activity, microbiota composition, microbial metabolites, and performance in athletes. ResultsEndurance training induces microbial adaptations, including increases in taxa metabolizing lactate and generating propionate. Strength and HIIT training show more variable changes shaped by diet, training load, and metabolic health. Microbial metabolites—especially SCFAs—may enhance energy regulation, immune balance, and gut barrier function, though evidence remains fragmented and causality unclear. ConclusionThe gut microbiota is a dynamic component of exercise adaptation. While diverse and SCFA-producing microbes appear beneficial for metabolism, inflammation control, and recovery, overall findings are heterogeneous. More interdisciplinary research is needed to clarify causal pathways and support personalized, microbiome-based strategies in sports nutrition and training.
- Open Access
- 26 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Fertility - preserving treatment strategies for adult and pediatric malignancies - current state of knowledge
Introduction and purpose:The global incidence of malignant tumors is rising, including among young adults who may not yet have considered parenthood. While improved oncological treatments have increased survival rates, they often carry the risk of gonadotoxicity, leading to infertility. This growing challenge has contributed to the development of oncofertility - an interdisciplinary field combining oncology, reproductive medicine, endocrinology, embryology, psychology, and ethics. This article aims to review current literature, highlight recent advances, and discuss available fertility preservation strategies for cancer patients. Material and methods:A literature review was conducted using PubMed, Embase, and Google Scholar databases with relevant keywords. State of knowledge:Fertility preservation is feasible in many oncology patients, provided it is discussed prior to initiating treatment. Informed consent, particularly for minors, must involve guardians. For postpubertal males, sperm cryopreservation is the standard; testicular tissue preservation remains experimental, especially in prepubertal boys. Female patients have more options: oocyte or embryo cryopreservation are preferred, depending on partner status and treatment timeline. Ovarian tissue cryopreservation, though still experimental in children, is an option. Ovarian transposition before radiotherapy and hormonal protection are considered complementary approaches. Conclusions:Cancer therapies can significantly impair reproductive function, affecting quality of life. Despite rapid advances in oncofertility, no method guarantees future fertility. Early patient education and individualized care are essential to maximizing reproductive outcomes post-treatment.
- 26 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Open AccessFertility - preserving treatment strategies for adult and pediatric malignancies - current state of knowledge
Introduction and purpose:The global incidence of malignant tumors is rising, including among young adults who may not yet have considered parenthood. While improved oncological treatments have increased survival rates, they often carry the risk of gonadotoxicity, leading to infertility. This growing challenge has contributed to the development of oncofertility - an interdisciplinary field combining oncology, reproductive medicine, endocrinology, embryology, psychology, and ethics. This article aims to review current literature, highlight recent advances, and discuss available fertility preservation strategies for cancer patients. Material and methods:A literature review was conducted using PubMed, Embase, and Google Scholar databases with relevant keywords. State of knowledge:Fertility preservation is feasible in many oncology patients, provided it is discussed prior to initiating treatment. Informed consent, particularly for minors, must involve guardians. For postpubertal males, sperm cryopreservation is the standard; testicular tissue preservation remains experimental, especially in prepubertal boys. Female patients have more options: oocyte or embryo cryopreservation are preferred, depending on partner status and treatment timeline. Ovarian tissue cryopreservation, though still experimental in children, is an option. Ovarian transposition before radiotherapy and hormonal protection are considered complementary approaches. Conclusions:Cancer therapies can significantly impair reproductive function, affecting quality of life. Despite rapid advances in oncofertility, no method guarantees future fertility. Early patient education and individualized care are essential to maximizing reproductive outcomes post-treatment.
- Open Access
- 25 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
The Impact of Nephrostomy on Urinary Tract Infections – A Literature Review
Background: Percutaneous nephrostomy (PCN) is a minimally invasive procedure used to decompress the renal collecting system in cases of urinary tract obstruction. Although effective, it introduces an external drainage system that increases the risk of urinary tract infections (UTIs), especially catheter-associated UTIs (CAUTIs), due to direct microbial access. Aim: This study aims to analyze the incidence, mechanisms, risk factors, microbial profiles, clinical management, and prevention strategies of UTIs associated with PCN. Material and Methods: A systematic review was performed using PubMed, Scopus, Web of Science, and Google Scholar, covering publications from 2000 to 2025. Included studies involved adult patients undergoing PCN. The synthesis was narrative and focused on epidemiology, pathophysiology, and prevention. Results: UTIs occur in up to 35% of PCN patients. Key risk factors include prolonged catheterization, inadequate aseptic technique, and multidrug-resistant organisms. Biofilm formation on catheter surfaces plays a central role in pathogenesis. CAUTI incidence ranges from 8% to 40%, influenced by catheter dwell time, patient comorbidities, and catheter care. Predominant pathogens include Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa, with an increasing presence of resistant strains. Preventive measures include strict asepsis, regular catheter exchange, rational antibiotic use, and patient education. Conclusions: PCN increases the risk of UTIs due to its invasive nature and biofilm-related colonization. A multifaceted prevention approach combining technical precision, infection monitoring, and improved catheter design is essential to reduce CAUTI rates in PCN patients.
- 25 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Open AccessThe Impact of Nephrostomy on Urinary Tract Infections – A Literature Review
Background: Percutaneous nephrostomy (PCN) is a minimally invasive procedure used to decompress the renal collecting system in cases of urinary tract obstruction. Although effective, it introduces an external drainage system that increases the risk of urinary tract infections (UTIs), especially catheter-associated UTIs (CAUTIs), due to direct microbial access. Aim: This study aims to analyze the incidence, mechanisms, risk factors, microbial profiles, clinical management, and prevention strategies of UTIs associated with PCN. Material and Methods: A systematic review was performed using PubMed, Scopus, Web of Science, and Google Scholar, covering publications from 2000 to 2025. Included studies involved adult patients undergoing PCN. The synthesis was narrative and focused on epidemiology, pathophysiology, and prevention. Results: UTIs occur in up to 35% of PCN patients. Key risk factors include prolonged catheterization, inadequate aseptic technique, and multidrug-resistant organisms. Biofilm formation on catheter surfaces plays a central role in pathogenesis. CAUTI incidence ranges from 8% to 40%, influenced by catheter dwell time, patient comorbidities, and catheter care. Predominant pathogens include Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa, with an increasing presence of resistant strains. Preventive measures include strict asepsis, regular catheter exchange, rational antibiotic use, and patient education. Conclusions: PCN increases the risk of UTIs due to its invasive nature and biofilm-related colonization. A multifaceted prevention approach combining technical precision, infection monitoring, and improved catheter design is essential to reduce CAUTI rates in PCN patients.